Skip to main content

Table 4 MDC per sex, outcome, place of birth, mode of delivery and corticosteroids

From: Evaluating the medical direct costs associated with prematurity during the initial hospitalization in Rwanda: a prevalence based cost of illness study

Variable

Category

Average RWF (US$)

Maximum RWF (US$)

Minimum RWF (US$)

Sex

Female

239,733 (244.6)

1,538,049 (1569.4)

14,977 (15.2)

Male

225,626 (230.2)

1,283,473 (1309.6)

11,598 (11.8)

Outcome

Improved

216,229 (220.6)

1,538,049 (1569.4)

11,598 (11.8)

Referred

481,485 (491.3)

760,837 (776.3)

171,604 (175.1)

Died

306,442 (312.7)

654,020 (667.3)

63,100 (64.3)

Place of birth

Hospital study

240,867 (245.7)

1,538,049 (1569.4)

11,598 (11.8)

HC of hospital study

171,017 (174.5)

434,326.40 (443.1)

14,976.54 (15.2)

HC of another hospital

357,228 (364.5)

760,837 (776.3)

200,777 (204.8)

Home BW

202,679 (206.8)

1,033,906 (1055.0)

17,835 (18.2)

In another hospital

229,944 (234.6)

345,304 (352.3)

169,972 (173.4)

Corticosteroids

Taken

517,483 (528.0)

1,396,051 (1424.5)

124,841 (127.3)

Not taken

263,611 (268.9)

1,538,049 (1569.4)

11,598 (11.8)

Mode of delivery

Normal delivery

256,734 (261.9)

1,396,051 (1424.5)

11,598 (11.8)

C section

183,648 (187.4)

1,538,049 (1569.4)

22,123 (22.5)